Effect of hyperthermia on the formation and removal of DNA interstrand cross-links induced by melphalan in primary cultures of human malignant melanoma

References

• Barlogie B., Corry P. M., Drewinko B. In vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiammineplatinum II and mitomycin C. Cancer Research 1980; 40: 1165–1168
   PubMed Web of Science ®Google Scholar
• Cordell J. L., Falini B., Erber W., Ghosh A. K., Abdulaziz Z., Macdonald S., Pulford K., Stein H., Mason D. Y. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). Journal of Histochemistry and Cytochemistry 1984; 32: 219–229
   PubMed Web of Science ®Google Scholar
• Drewinko B., Loo T. L., Brown B., Gottlieb J. A., Freireich E. J. Combination chemotherapy in vitro with adriamycin. Observation of additive, antagonistic, and synergistic effects when used in two-drug combinations on cultured human lymphoma cells. Cancer Biochemistry and Biophysics 1976; 1: 187–195
   PubMedGoogle Scholar
• Ghussen F., Kruger I., Growth W., Stutzer H. The role of regional hyperthermic perfusion in the treatment of extremity melanoma. Cancer 1988; 61: 654–659
   PubMed Web of Science ®Google Scholar
• Goss P., Parson P. G. The effect of hyperthermia and melphalan on survival of human fibroblast strains and melanoma cell lines. Cancer Research 1977; 37: 152–156
   PubMed Web of Science ®Google Scholar
• Hansson J., Lewensohn R., Ringborg U., Nilson B. Formation and removal of DNA cross-links induced by melphalan and nitrogen mustard in relation to drug-induced cytotoxicity in human melanoma cells. Cancer Research 1987; 47: 2631–2637
   PubMed Web of Science ®Google Scholar
• Herman T. S., Teicher B. A., Cathcart K. N. S., Kaufmann M. E., Lee J. B., Lee M. Effect of hyperthermia on cis-diamminedichloroplatinum(II) (rhodamine-123)2 [tetrachloroplatinum(II)] in a human squamous cell carcinoma line and a Cis-diamminedichloro-platinum(II)-resistant subline. Cancer Research 1988; 48: 5101–5105
   PubMed Web of Science ®Google Scholar
• Hospers G. A. P., Meijer C., van Leij L., Dges D. R. A., Mulder N. H., De Vries E. G. E. A study of human small-cell lung carcinoma (HSCLC) cell lines with different sensitivities to detect relevant mechanisms of cisplatin (CDDP) resistance. International Journal of Cancer 1990; 46: 138–144
   PubMed Web of Science ®Google Scholar
• Kelley S. L., Basu A., Teicher B. A., Hacker M. P., Hamer D. H., Lazo J. S. Overexpression of metallothionein confers resistance to anticancer drugs. Science 1988; 241: 1813–1815
   PubMed Web of Science ®Google Scholar
• Kern D. H., Drogemuller C. R., Kennedy M. C., Hildebrand-Zanki S. U., Tanigawa N., Sondak V. K. Development of a miniaturized improved nucleic acid precursor incorporation assay for chemosensitivity testing of human solid tumors. Cancer Research 1985; 45: 5436–5441
   PubMed Web of Science ®Google Scholar
• Kohn K. W. DNA as a target in cancer chemotherapy: measurement of macromolecular DNA damage produced in mammalian cells by anticancer agents and carcinogens. Methods in Cancer Research 1979; 16: 291–298
   Google Scholar
• Kohn K. W. Molecular mechanisms of cross-linking by alkylating agents and platinum complexes. Molecular Actions and Targets for Cancer Chemotherapeutic Agents, A. C. Sartorelli, J. S. Lazlo, J. R. Bertino. Academic Press, New York 1981; 3–16
   Google Scholar
• Kohn K. W., Ewing R. A. G., Erickson L. C., Zwelling L. Measurement of strand breaks and cross-links in DNA by alkaline elution. DNA Repair. A Laboratory Manual of Research Procedures, E. C. Friedberg, P. C. Hanawalt. Marcell Dekker, New York 1981; Vol. 1: 379–401
   Google Scholar
• Lucas V. S., Huang A. T. Chemotherapy of melanoma. Clinical Management of Melanoma, H. F. Seigler. Martnus Nijhoff, The Hague 1982; 381–404
   Google Scholar
• Masuda H., Ozols R. F., Lai G. M., Fojo A., Rothengerg M., Hamilton T. C. Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum(II) in human ovarian cancer cell lines. Cancer Research 1988; 48: 5713–5716
   PubMed Web of Science ®Google Scholar
• Neilan B. A., Henle K. J., Nagle W. A., Moss A. J. Cytotoxicity of hyperthermia combined with bleomycin and cisplatinum in cultured RIF cells: modification by thermotolerance and by polyhydroxyl compounds. Cancer Research 1988; 48: 2245–2247
   PubMedGoogle Scholar
• Neumann H. A., Fiebig H. H., Lohr G. W., Engelhardt R. Effects of cytostatic drugs and 40·5°C hyperthermia on human clonogenic tumor cells. European Journal of Cancer and Clinical Oncology 1985; 21: 515–523
   PubMedGoogle Scholar
• Santinami M., Belli F., Cascinelli N., Rovini D., Vaglini M. Seven years experience with hyperthermic perfusions in extracorporeal circulation for melanoma of the extremities. Journal of Surgical Oncology 1989; 42: 201–208
   PubMed Web of Science ®Google Scholar
• Tanigawa N., Kern D. H., Hikasa Y., Morton D. L. Rapid assay for evaluating the chemosensitivity of human tumors in soft-agar culture. Cancer Research 1982; 42: 2159–2164
   PubMed Web of Science ®Google Scholar
• Thicher B. A., Holden S. A., Kelley H. J., Shea T. C., Cijcchi C. A., Rosowsky A., Henner W. D., Frei E. Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II). Cancer Research 1987; 47: 388–393
   PubMed Web of Science ®Google Scholar
• Vaglini M., Santinami M., Nava M., Belli F., Prada A., Ammatuna M., Cascinelli N. Hyperthermic antiblastic perfusion in extracorporeal circulation: surgical technique and results in the treatment of extremities tumor. Journal of Extracorporeal Technology 1986; 18: 13–20
   Google Scholar
• Zaffaroni N., Villa R., Daidone M. G., Vaglini M., Santinami M., Silvestrini R. Antitumor activity of hyperthermia alone or in combination with cisplatin and melphalan in primary cultures of human malignant melanoma. International Journal of Cell Cloning 1989; 7: 385–394
   PubMedGoogle Scholar